119th Congress · introduced in the Senate · Oct 30, 2025
Nitazene Control Act
Official title from Congress.gov
Latest action (Oct 30, 2025): Read twice and referred to the Committee on the Judiciary.
View on Congress.govPolicy area: Crime and Law Enforcement
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Read twice and referred to the Committee on the Judiciary.
Introduced in Senate
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
12 citations.
NATIONAL ALLIANCE ON MENTAL ILLNESS · lobbying firm or registrant: NATIONAL ALLIANCE ON MENTAL ILLNESS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$10,000
Spent on own lobbying
…988 Lifeline Location Improvement Act: creates an advisory committee to study and recommend a solution for transmitting geolocation information with 988 calls. S. 3076 Nitazene Control Act: permanently classifies all nitazene opioids as schedule 1 Support for improving integrated care for those with Tardive Dyskinesia H.R. 62…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE SENTENCING PROJECT · lobbying firm or registrant: THE SENTENCING PROJECT
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
Amount not reported
…to Cash Act Oppose S. 3398Stop Sextortion Act Oppose S. 3397ECCHO Act Oppose S. 3394SAFE Act Oppose S. 1572Federal Carjacking Enforcement Act Oppose H.R. 5415 /S. 3076Nitazene Control Act Oppose H.R. 1266/S. 545Combating Illicit Xylazine Act Oppose H.R. 7970STOP Nitazenes Act Oppose
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. View filing
DUE PROCESS INSTITUTE · lobbying firm or registrant: DUE PROCESS INSTITUTE
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Aug 13, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$15,000
Spent on own lobbying
…the DC Juvenile Sentencing Reform Act (H.R. 5140); supporting the FIX Clemency Act; supporting the ED ACCESS Act; opposing the Nitazene Control Act (H.R. 5415 /S. 3076) and STOP Nitazenes Act (H.R. 7970); opposing the Keep Violent Criminals Off Our Streets Act (H.R. 6260), and supporting legislation to reform the Armed Career…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ALLIANCE ON MENTAL ILLNESS · lobbying firm or registrant: NATIONAL ALLIANCE ON MENTAL ILLNESS
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$20,000
Spent on own lobbying
…988 Lifeline Location Improvement Act: creates an advisory committee to study and recommend a solution for transmitting geolocation information with 988 calls. S. 3076 Nitazene Control Act: permanently classifies all nitazene opioids as schedule 1 Support for improving integrated care for those with Tardive Dyskinesia H.R. 62…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN CIVIL LIBERTIES UNION · lobbying firm or registrant: AMERICAN CIVIL LIBERTIES UNION
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Civil Rights/Civil Liberties
$670,000
Spent on own lobbying
…ve Rights. S. 3054-Kayla Hamilton Act-Issues Lobbied: Immigration. S. 1071-National Defense Authorization Act for Fiscal Year 2026-Issues Lobbied: Citizenship. S. 3076-Nitazene Control Act-Issues Lobbied: Drug Policy. S.J.Res. 99-A joint resolution providing for congressional disapproval under chapter 8 of title 5, United Sta…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE SENTENCING PROJECT · lobbying firm or registrant: THE SENTENCING PROJECT
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$14,111
Spent on own lobbying
…to Cash Act Oppose S. 3398Stop Sextortion Act Oppose S. 3397ECCHO Act Oppose S. 3394SAFE Act Oppose S. 1572Federal Carjacking Enforcement Act Oppose H.R. 5415 /S. 3076Nitazene Control Act Oppose H.R. 1266/S. 545Combating Illicit Xylazine Act Oppose H.R. 7970STOP Nitazenes Act Oppose
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DRUG POLICY ALLIANCE · lobbying firm or registrant: DRUG POLICY ALLIANCE
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 17, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$18,639
Spent on own lobbying
…is Administration and Opportunity Act in the Senate. We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DUE PROCESS INSTITUTE · lobbying firm or registrant: DUE PROCESS INSTITUTE
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Jun 1, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$15,000
Spent on own lobbying
…the DC Juvenile Sentencing Reform Act (H.R. 5140); supporting the FIX Clemency Act; supporting the ED ACCESS Act; opposing the Nitazene Control Act (H.R. 5415 /S. 3076) and STOP Nitazenes Act (H.R. 7970); opposing the Keep Violent Criminals Off Our Streets Act (H.R. 6260), and supporting legislation to reform the Armed Career…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE SENTENCING PROJECT · lobbying firm or registrant: THE SENTENCING PROJECT
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
$17,342
Spent on own lobbying
…to Cash Act Oppose S. 3398Stop Sextortion Act Oppose S. 3397ECCHO Act Oppose S. 3394SAFE Act Oppose S. 1572Federal Carjacking Enforcement Act Oppose H.R. 5415 /S. 3076Nitazene Control Act Oppose H.R. 1266/S. 545Combating Illicit Xylazine Act Oppose H.R. 7970STOP Nitazenes Act Oppose
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DRUG POLICY ALLIANCE · lobbying firm or registrant: DRUG POLICY ALLIANCE
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 19, 2026 · issue area: Law Enforcement/Crime/Criminal Justice
Amount not reported
…to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. View filing
NATIONAL ALLIANCE ON MENTAL ILLNESS · lobbying firm or registrant: NATIONAL ALLIANCE ON MENTAL ILLNESS
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 16, 2026 · issue area: Health Issues
$10,000
Spent on own lobbying
…988 Lifeline Location Improvement Act: creates an advisory committee to study and recommend a solution for transmitting geolocation information with 988 calls. S. 3076 Nitazene Control Act: permanently classifies all nitazene opioids as schedule 1 Support for improving integrated care for those with Tardive Dyskinesia H.R. 62…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ALLIANCE ON MENTAL ILLNESS · lobbying firm or registrant: NATIONAL ALLIANCE ON MENTAL ILLNESS
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Health Issues
$10,000
Spent on own lobbying
…988 Lifeline Location Improvement Act: creates an advisory committee to study and recommend a solution for transmitting geolocation information with 988 calls. S. 3076 Nitazene Control Act: permanently classifies all nitazene opioids as schedule 1 Support for improving integrated care for those with Tardive Dyskinesia
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing